Next Article in Journal
Induction of p53-Independent Apoptosis and G1 Cell Cycle Arrest by Fucoidan in HCT116 Human Colorectal Carcinoma Cells
Next Article in Special Issue
Borrelidins C–E: New Antibacterial Macrolides from a Saltern-Derived Halophilic Nocardiopsis sp.
Previous Article in Journal
Collagen from the Marine Sponges Axinella cannabina and Suberites carnosus: Isolation and Morphological, Biochemical, and Biophysical Characterization
Previous Article in Special Issue
Antibacterial Activities of Bacteria Isolated from the Marine Sponges Isodictya compressa and Higginsia bidentifera Collected from Algoa Bay, South Africa
Article Menu
Issue 6 (June) cover image

Export Article

Open AccessCommunication
Mar. Drugs 2017, 15(6), 153; doi:10.3390/md15060153

Chalcomycins from Marine-Derived Streptomyces sp. and Their Antimicrobial Activities

1
Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine & New Drug Research, Jinan University, Guangzhou 510632, China
2
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Wuhan University, Ministry of Education, and Wuhan University School of Pharmaceutical Sciences, Wuhan 430071, China
3
Food and Drug Department, Qingyuan Polytechnic, Qingyuan 511510, China
These authors have contributed equally to this work.
*
Authors to whom correspondence should be addressed.
Received: 8 March 2017 / Revised: 10 May 2017 / Accepted: 22 May 2017 / Published: 29 May 2017
(This article belongs to the Special Issue Antibacterial Marine Pharmacology)
View Full-Text   |   Download PDF [790 KB, uploaded 31 May 2017]   |  

Abstract

Dihydrochalcomycin (1) and chalcomycin, (2), two known chalcomycins, and chalcomycin E (3), a new compound, were isolated from marine-derived Streptomyces sp. HK-2006-1. Their structures were elucidated by detailed spectroscopic and X-ray crystallographic analysis. The antimicrobial activities against Staphylococcus aureus, Escherichia coli, Candida albicans, and Aspergillus niger of 1–3 were evaluated. Compounds 1–2 exhibited activities against S. aureus with minimal inhibitory concentrations (MICs) of 32 µg/mL and 4 µg/mL, respectively. The fact that 1–2 showed stronger activity against S. aureus 209P than 3 indicated that the epoxy unit was important for antimicrobial activity. This structure–activity tendency of chalcomycins against S. aureus is different from that of aldgamycins reported in our previous research, which provide a valuable example for the phenomenon that 16-membered macrolides with different sugars do not have parallel structure–activity relationships. View Full-Text
Keywords: marine-derived Streptomyces; secondary metabolite; 16-membered macrolide; chalcomycin E; antimicrobial activity marine-derived Streptomyces; secondary metabolite; 16-membered macrolide; chalcomycin E; antimicrobial activity
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Jiang, S.; Zhang, L.; Pei, X.; Deng, F.; Hu, D.; Chen, G.; Wang, C.; Hong, K.; Yao, X.; Gao, H. Chalcomycins from Marine-Derived Streptomyces sp. and Their Antimicrobial Activities. Mar. Drugs 2017, 15, 153.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top